63 phenotypes from 5 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Fah1R/Fah1R involves: BALB/cRl * C3H/Rl * C57BL/10Rl	abnormal urine homeostasis	J:54592
	neonatal lethality, complete penetrance	J:54592
Fah2R/Fah2R involves: BALB/cRl	abnormal urine homeostasis	J:54592
	postnatal lethality, complete penetrance	J:54592
Fahem1(IMPC)Mbp/Fah+ C57BL/6N-Fahem1(IMPC)Mbp/MbpMmucd	abnormal heart morphology	J:211773
	abnormal kidney morphology	J:211773
	abnormal liver morphology	J:211773
	abnormal placenta morphology	J:211773
	abnormal placenta vasculature	J:211773
	abnormal retina blood vessel morphology	J:211773
	abnormal retina vasculature morphology	J:211773
	abnormal skin morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal testis morphology	J:211773
	embryonic growth retardation	J:211773
	enlarged heart	J:211773
	enlarged kidney	J:211773
	enlarged spleen	J:211773
	enlarged testis	J:211773
	persistence of hyaloid vascular system	J:211773
	small kidney	J:211773
	small liver	J:211773
Fahem1(IMPC)Mbp/Fahem1(IMPC)Mbp C57BL/6N-Fahem1(IMPC)Mbp/MbpMmucd	abnormal blood vessel morphology	J:211773
	abnormal placenta morphology	J:211773
	abnormal placenta vasculature	J:211773
	edema	J:211773
	preweaning lethality, complete penetrance	J:211773
Fahswst/Fahswst C57BL/6J-Fahswst/Nwu	abnormal sleep pattern	J:98867
Fahtm1Mgo/Fahtm1Mgo either: (involves: 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)	abnormal circulating aspartate transaminase level	J:16046
	hypoglycemia	J:16046
	increased circulating creatinine level	J:16046
	neonatal lethality, complete penetrance	J:16046
Fahtm1Mgo/Fahtm1Mgo involves: 129S7/SvEvBrd	decreased hepatocyte apoptosis	J:105440
	increased susceptibility to xenobiotic induced morbidity/mortality	J:105440
	liver failure	J:105440
Fahtm1Mgo/Fahtm1Mgo involves: 129S7/SvEvBrd * C57BL	abnormal amino acid level	J:27735
	abnormal circulating amino acid level	J:27735
	abnormal hepatocyte mitochondrial morphology	J:27735
	abnormal hepatocyte morphology	J:27735
	abnormal hepatocyte physiology	J:27735
	abnormal liver lobule morphology	J:27735
	aminoaciduria	J:27735
	enlarged kidney	J:27735
	increased alpha-fetoprotein level	J:27735
	increased circulating aspartate transaminase level	J:27735
	increased circulating bilirubin level	J:27735
	increased circulating tyrosine level	J:27735
	increased hepatocellular carcinoma incidence	J:27735
	increased hepatoma incidence	J:27735
	increased liver adenoma incidence	J:27735
	increased liver tumor incidence	J:27735
	increased pancreatic alpha cell number	J:27735
	kidney degeneration	J:27735
	liver inflammation	J:27735
	normal liver/biliary system phenotype	J:27735
	neonatal lethality, complete penetrance	J:27735
	pale kidney	J:27735
	pancreas hyperplasia	J:27735
Fahtm1Mgo/Fahtm1Mgo involves: 129S7/SvEvBrd * C57BL/6	abnormal hepatocyte morphology	J:138701
	abnormal liver physiology	J:138701
	abnormal liver regeneration	J:138701
	aminoaciduria	J:138701
	decreased hepatocyte proliferation	J:138701
	enlarged kidney	J:138701
	impaired liver regeneration	J:138701
	increased hepatocellular carcinoma incidence	J:138701
	increased susceptibility to induced morbidity/mortality	J:138701
	increased susceptibility to injury	J:138701
	weight loss	J:138701
Fahtm1Mgo/Fahtm1Mgo involves: 129S7/SvEvBrd * PT	abnormal liver physiology	J:77295
	dilated renal tubule	J:77295
	increased circulating tyrosine level	J:77295
	jaundice	J:77295
	kidney inflammation	J:77295
	pale liver	J:77295
	weight loss	J:77295